240 related articles for article (PubMed ID: 30725486)
21. The increased but non-predominant expression of Th17- and Th1-specific cytokines in Hashimoto's thyroiditis but not in Graves' disease.
Qin Q; Liu P; Liu L; Wang R; Yan N; Yang J; Wang X; Pandey M; Zhang JA
Braz J Med Biol Res; 2012 Dec; 45(12):1202-8. PubMed ID: 23090124
[TBL] [Abstract][Full Text] [Related]
22. Clustering of additional autoimmunity behaves differently in Hashimoto's patients compared with Graves' patients.
Wiebolt J; Achterbergh R; den Boer A; van der Leij S; Marsch E; Suelmann B; de Vries R; van Haeften TW
Eur J Endocrinol; 2011 May; 164(5):789-94. PubMed ID: 21378091
[TBL] [Abstract][Full Text] [Related]
23. The effect of acylated polyamine derivatives on polyamine uptake mechanism, cell growth, and polyamine pools in Escherichia coli, and the pursuit of structure/activity relationships.
Karahalios P; Mamos P; Vynios DH; Papaioannou D; Kalpaxis DL
Eur J Biochem; 1998 Feb; 251(3):998-1004. PubMed ID: 9490078
[TBL] [Abstract][Full Text] [Related]
24. Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls.
Kristensen B
Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836805
[TBL] [Abstract][Full Text] [Related]
25. Circulating microRNAs in autoimmune thyroid diseases.
Yamada H; Itoh M; Hiratsuka I; Hashimoto S
Clin Endocrinol (Oxf); 2014 Aug; 81(2):276-81. PubMed ID: 24533739
[TBL] [Abstract][Full Text] [Related]
26. Alterations in the amino acid profile in patients with papillary thyroid carcinoma with and without Hashimoto's thyroiditis.
Hellmann A; Turyn J; Zwara A; Korczynska J; Taciak A; Mika A
Front Endocrinol (Lausanne); 2023; 14():1199291. PubMed ID: 37664829
[TBL] [Abstract][Full Text] [Related]
27. Serum CD40/CD40L system in Graves' disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response.
Mysliwiec J; Oklota M; Nikolajuk A; Waligorski D; Gorska M
Immunol Invest; 2007; 36(3):247-57. PubMed ID: 17558708
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and clinical relevance of thyroid stimulating hormone receptor-blocking antibodies in autoimmune thyroid disease.
Diana T; Krause J; Olivo PD; König J; Kanitz M; Decallonne B; Kahaly GJ
Clin Exp Immunol; 2017 Sep; 189(3):304-309. PubMed ID: 28439882
[TBL] [Abstract][Full Text] [Related]
29. In young patients with Turner or Down syndrome, Graves' disease presentation is often preceded by Hashimoto's thyroiditis.
Aversa T; Lombardo F; Corrias A; Salerno M; De Luca F; Wasniewska M
Thyroid; 2014 Apr; 24(4):744-7. PubMed ID: 24325626
[TBL] [Abstract][Full Text] [Related]
30. The expression and distribution of S-100 protein and CD 83 in thyroid tissues of autoimmune thyroid diseases.
Xu W; Chen S; Huang J; Zheng Z; Chen L; Zhang W
Cell Mol Immunol; 2004 Oct; 1(5):378-82. PubMed ID: 16285898
[TBL] [Abstract][Full Text] [Related]
31. Serum prolidase levels in Graves' disease without ophthalmopathy and its association with oxidative status.
Korkmaz H; Tabur S; Ozkaya M; Oguz E; Aksoy N; Akarsu E
J Endocrinol Invest; 2015 Nov; 38(11):1167-73. PubMed ID: 25900177
[TBL] [Abstract][Full Text] [Related]
32. Decreased proportions of CD4 + IL17+/CD4 + CD25 + CD127- and CD4 + IL17+/CD4 + CD25 + CD127 - FoxP3+ T cells in children with autoimmune thyroid diseases (.).
Bossowski A; Moniuszko M; Idźkowska E; Grubczak K; Singh P; Bossowska A; Diana T; Kahaly GJ
Autoimmunity; 2016 Aug; 49(5):320-8. PubMed ID: 27206624
[TBL] [Abstract][Full Text] [Related]
33. Assessment of serum dipeptidyl peptidase-IV levels in autoimmune thyroid disease.
Zhang Y; Fu Y; Yang Y; Ke J; Zhao D
J Int Med Res; 2022 Jul; 50(7):3000605221112031. PubMed ID: 35903860
[TBL] [Abstract][Full Text] [Related]
34. Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies.
Latrofa F; Ricci D; Grasso L; Vitti P; Masserini L; Basolo F; Ugolini C; Mascia G; Lucacchini A; Pinchera A
J Clin Endocrinol Metab; 2008 Feb; 93(2):591-6. PubMed ID: 18029466
[TBL] [Abstract][Full Text] [Related]
35. Functional TSH receptor antibodies in children with autoimmune thyroid diseases.
Stożek K; Bossowski A; Ziora K; Bossowska A; Mrugacz M; Noczyńska A; Walczak M; Petriczko E; Pyrżak B; Kucharska A; Szalecki M; Diana T; Kahaly GJ
Autoimmunity; 2018 Mar; 51(2):62-68. PubMed ID: 29372654
[TBL] [Abstract][Full Text] [Related]
36. High prevalence of thyroid hormone autoantibody and low rate of thyroid hormone detection interference.
Ni J; Long Y; Zhang L; Yang Q; Kou C; Li S; Li J; Zhang H
J Clin Lab Anal; 2022 Jan; 36(1):e24124. PubMed ID: 34850456
[TBL] [Abstract][Full Text] [Related]
37. Role of the Specialized Pro-resolving Mediator Resolvin D1 in Hashimoto's Thyroiditis.
Song J; Sun R; Zhang Y; Fu Y; Zhao D
Exp Clin Endocrinol Diabetes; 2021 Nov; 129(11):791-797. PubMed ID: 33465800
[TBL] [Abstract][Full Text] [Related]
38. Putrescine, polyamines, and N1-acetylpolyamine levels in retina, visual cortex and cerebellum of free-running mice kept under continuous light or darkness.
Macaione S; Cangemi F; Fabiano C; Crisafulli G; Aronica T; Ientile R
Ital J Biochem; 1993; 42(3):151-64. PubMed ID: 8407267
[TBL] [Abstract][Full Text] [Related]
39. Comparison of thyroglobulin and thyroid peroxidase antibodies measured by five different kits in autoimmune thyroid diseases.
Nishihara E; Amino N; Kudo T; Ito M; Fukata S; Nishikawa M; Nakamura H; Miyauchi A
Endocr J; 2017 Oct; 64(10):955-961. PubMed ID: 28768936
[TBL] [Abstract][Full Text] [Related]
40. Single nucleotide polymorphisms in the STAT3 gene influence AITD susceptibility, thyroid autoantibody levels, and IL6 and IL17 secretion.
Kotkowska A; Sewerynek E; Domańska D; Pastuszak-Lewandoska D; Brzeziańska E
Cell Mol Biol Lett; 2015 Mar; 20(1):88-101. PubMed ID: 26204395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
